Author Archive

The Climate Alarmism Grift is Dying

https://timlynch.substack.com/p/the-climate-alarmism-grift-is-dying?

The Climate Alarmism Grift is Dying

Tim Lynch
Jul 08, 2025

Last week, the BBC reminded us that we have just three years left to drastically reduce all CO2 emissions, or we risk crossing the dreaded 1.5°C warming limit set by the Paris Agreement. A persistent feature of the degreed managerial class is their arrogant refusal to learn from their past flawed predictions. Dire warnings of climate catastrophe have shaped global policy, media narratives, and public perception, resulting in the waste of hundreds of billions of dollars on technology that does not work. Predictions by climate ‘experts’ of submerged cities, the end of snow, vanishing ice caps, and dead coral formations never materialize.

Thinking that highly credentialed Ivy League professors would use science and math to destroy the man-made climate change narrative was not plausible a year ago. Yet, in this new cultural zeitgeist created after the implosion of the Democratic Party, the impossible is now possible.

In a shocking display of academic integrity, two eminent professors published a masterfully complex paper that undermines the foundation of climate alarmism. MIT’s Richard Lindzen, Professor of Earth, Atmospheric, and Planetary Sciences, Emeritus, and Princeton’s William Happer, Professor of Physics, Emeritus, published a paper titled PHYSICS DEMONSTRATES THAT INCREASING GREENHOUSE GASES CANNOT CAUSE DANGEROUS WARMING, EXTREME WEATHER OR ANY HARM.

Their message is simple: CO2-driven warming poses no danger to the planet, while the net-zero policies designed to reduce CO2 do more harm than good. It takes a paper of serious complexity to validate such a simple message.  (See link for article & unbelievable dire forecasts)

____________

**Comment**

The authors state CO2 is enhancing life by supercharging plant growth and delivering bountiful harvests at unprecedented rates.

Well, we can’t have that.

We must dim the sun to extinguish all life on planet earth!

Climate activists reacted to the paper as expected: they want the authors arrested and jailed.  How’s that for free speech?

I highly recommend John Stossel’s excellent video destroying climate change myths, as well as the longer documentary – Climate: The Movie.

‘Science’ wrong about ‘global warming’ for over 50 years but refuses to admit fault or reform.

Lastly, researchers are by trade myopic. They rarely look at the big picture and reality is far different than a test-tube.  Sadly, climate research is rife with this myopia.

For instance, a groundbreaking study from the University of Nebraska  reveals that cows are actually carbon negative and that they produce MORE oxygen than the methane and carbon they emit.  The pastures where they graze can capture more emissions than what the cattle produce & also offset methane.]  You have to look at all the pertinent variables, not just a singular entity.

For more:

Similarly to the deadly mRNA clot shots, it doesn’t appear to matter how many scientific papers come out or how many experts speak out – the narrative continues on unabated.

Category:

Activism, Climate

When Lyme Is Not Lyme: CDC and FDA Policies and Medical Practice Must Be Refined to Embrace Complexities For the Good of the Patient

https://popularrationalism.substack.com/p/when-lyme-is-not-lyme-cdc-and-fda?

When Lyme Is Not Lyme: CDC and FDA Policies and Medical Practice Must Be Refined to Embrace Complexities For the Good of the Patient

Here I propose a decision-tree based differential diagnosis of Lyme and Not Lyme. It’s a start.

James Lyons-Weiler, PhD
Aug 07, 2025

In the realm of infectious disease, simplicity is seductive. It promises clear diagnoses, standardized protocols, and neat narratives. But Lyme disease—a condition with protean manifestations, shifting microbial profiles, and diagnostic challenges at every stage—refuses to conform. It insists on complexity. And in response, our institutions—particularly the CDC and FDA—have built a regime of policies that actively deny it.

The result? A generation of patients misdiagnosed, underdiagnosed, or dismissed entirely—not because they lack illness, but because the illness they carry doesn’t fit the model. The model is wrong.

This article argues that regulatory science has reached a breaking point in Lyme disease policy. The failure to recognize nuanced diagnostic tools—especially direct detection technologies like PCR and sequencing—and the overreliance on antibody-based serologic paradigms are not only outdated, they are dangerous. The bucket-labeling of chronic illness under the guise of “post-treatment Lyme disease syndrome” or “functional somatic disorder” is not science. It is avoidance. It is bureaucracy masquerading as epidemiology.

We can—and must—do better.

The Tidy Algorithm That Misses the Patient

The CDC continues to recommend a two-tier serologic testing algorithm for Lyme disease diagnosis: an initial ELISA (enzyme-linked immunosorbent assay) or IFA (indirect fluorescent antibody), followed by a Western blot. But this cascade is built around the immune system’s delayed humoral response—one that may take weeks to develop and varies wildly across individuals.

Early localized Lyme disease—the phase where diagnosis and treatment are most crucial—often produces negative antibody tests despite active spirochetemia. The immune system hasn’t had time to respond, or responds atypically. Yet this window is precisely when patients present with acute symptoms—rash, fatigue, fever, malaise—and need confirmation.

Instead, they are sent home with instructions to “wait for antibodies to develop.” It is a ritual of deferred care masquerading as prudence.

Meanwhile, molecular techniques—such as PCR amplification of bacterial chromosomal DNA followed by Sanger sequencing—can detect Borrelia burgdorferi spirochetes in the blood of these patients with precision, even at very low organismal loads. A 2024 study confirmed the utility of the flaB gene as a sensitive target for direct molecular detection. And yet, CDC officials such as Dr. Christina Nelson continue to state—without qualification—that PCR is “not useful” in the diagnosis of Lyme disease, a systemic infectious disease. This “policy statement” on Lyme diagnosis contradicts CDC’s own established protocols for infectious diseases. For example, the CDC’s diagnostic protocol for SARS-CoV-1 in 2003 recommended using three specific primers to perform heminested PCR to amplify a 348-bp genomic cDNA for sequencing “to verify the authenticity of the amplified product” The CDC scientists also used Sanger sequencing of the nested PCR products to help diagnose the first SARS-CoV-2 case in this country.

The CDC does not recommend the Widal (serologic) test for diagnosing typhoid fever, a classic bacterial systemic infectious disease, which is usually diagnosed by blood cultures.

This is not simply a matter of differing interpretations. It is institutional self-contradiction, plain and harmful. On one hand, CDC acknowledges the superiority of molecular methods in select studies. On the other, its public guidance to clinicians categorically dismisses them. The result is diagnostic nihilism, not progress.

The Adjudicated Endpoint Mirage

This failure to adopt precise diagnostics bleeds into vaccine trials—most recently, those for Pfizer and Valneva’s VLA15, a candidate Lyme vaccine. The protocol allows for adjudication committees—not direct evidence—to determine whether a patient “truly” had Lyme disease based on serologic conversion.

In other words, the gold standard is not evidence of infection, but whether enough bureaucrats agree that a positive Western blot means what they want it to mean. This is a scientific sleight-of-hand: dressing bias in the costume of consensus.

We don’t adjudicate cancer diagnoses this way. We don’t require panels to decide if a culture grows MRSA. Why do we treat Lyme disease differently?

Because the system was designed around patented serologic tools, and because acknowledging more sensitive direct tests would expose three decades of flawed public health doctrine. The regulatory apparatus has become self-protective. It resists admitting new knowledge, even when it emerges from the very labs it funds.

The Individual’s Diagnostic Pathway: A Vanishing Art

Modern medicine must reclaim a lost art: tracing the pathway of illness in the individual patient. Lyme disease—and other stealth infections—do not conform to static models. They unfold dynamically, in stages, with overlapping presentations. Co-infections with Babesia, Bartonella, Ehrlichia, or Rickettsia are common and further blur the clinical picture. Immune exhaustion, biofilm states, immune complex sequestration—none of these phenomena are accounted for in the serologic testing regime.

And yet the CDC’s official diagnostic flowchart is oblivious to all of it.

This is not a technical problem. It is a philosophical one. To see illness clearly, one must be willing to dwell in ambiguity. To build robust diagnostics, one must test them against reality—not against regulatory convenience.

When a patient walks into a clinic with chronic fatigue, joint pain, or neurological complaints, physicians now reflexively reach for either a psychiatric label or a “fibromyalgia” diagnosis if the serology is negative. This is not differential diagnosis. It is abdication. And it is rooted in federal guidance that refuses to update.

A Better Framework: Evidence, Not Adjudication

It is not difficult to build a better system. We start by acknowledging that direct detection methods—when confirmed via sequencing—constitute definitive evidence of infection. A PCR test that amplifies Borrelia DNA and confirms identity through Sanger sequencing is objective, reproducible, and not susceptible to interpretive bias. Unlike a Western blot, there is no subjectivity in band intensity or background noise.

CDC must formally revise the case definition of Lyme disease to admit these tools. It must publish updated MMWRs and notify CLIA-certified labs that sequence-confirmed molecular diagnostics are not just permitted—they are necessary. And FDA, for its part, must refuse to approve any vaccine for Lyme disease that does not use culture-positive or sequencing-positive endpoints in its efficacy trials.

The adjudication committee must go the way of the phlogiston theory. It is an epistemic relic.

The Stakes: Chronic Illness Mismanagement on a National Scale

When Lyme is misdiagnosed, the result is not just diagnostic error. It is years of compounded harm—neurological decline, systemic inflammation, misprescribed psychiatric drugs, and social marginalization. And when regulators misdefine illness, insurance companies follow suit, refusing reimbursement for testing or treatment that strays from the flawed algorithm.

Thus, a person with real infection is told they are imagining it, or “have something else.” They are sent to psychiatrists, subjected to medications they don’t need, and denied the very antibiotic or herbal therapies that could help them.

This is not merely negligence. It is institutionalized medical error.

And the cost is not just individual. It is civilizational. When truth is buried beneath layers of bureaucratic adherence, science becomes theater.

Complexity Is Not the Enemy

To fix Lyme disease policy, we must abandon the false comfort of simplicity. Illness is not simple. Infection is not static. Patients are not algorithms.

The CDC and FDA must evolve to meet the complexity of this pathogen. And physicians must be permitted—indeed encouraged—to follow the diagnostic trail wherever it leads, even if that means sequencing a pathogen the government pretends not to see or looking for autoimmunity due to pathogenic priming from aluminum-containing vaccines that mimics Lyme.

In the end, it is not Borrelia burgdorferi that threatens public health the most. It is the system that refuses to learn from its past, revise its models, or admit that sometimes… Lyme is not just Lyme.  (See link for article)

_______________

For more:

Category:

Activism, Lyme, Testing, Treatment

Study Finds CDC Test Misses Most Cases of Early Lyme

https://www.lymedisease.org/lyme-biobank-study/

Lyme Biobank study finds CDC test misses most cases of early Lyme

BALF Lyme Biobank

July 11, 2025

A newly published study in Frontiers in Medicine reveals serious gaps in Lyme disease testing and post-treatment care, based on a decade of patient data collected by the Lyme Disease Biobank.

The research, supported by the Bay Area Lyme Foundation, followed 253 participants in Lyme-endemic areas of Long Island, New York, and Central Wisconsin between 2014 and 2023.

All presented signs of early Lyme disease, yet only 23% tested positive using the CDC’s recommended two-tiered test. Even among those with diagnostic Lyme rashes larger than five centimeters, just 34% tested positive.

The study also found that 21% of patients reported lingering symptoms—such as fatigue, joint pain, and muscle aches—three months after antibiotic treatment. Despite this, only 35% of those experiencing ongoing symptoms followed up with healthcare providers.

Early diagnosis is critical

“Accurate, timely detection of Lyme disease is critical to preventing long-term complications. Moreover, follow-up from medical professionals with all patients after they complete antibiotic treatment could  improve outcomes and reduce the burden of Lyme disease,” said lead author Liz Horn, PhD, MBI, Principal Investigator.

“Our data also confirm the limitations of serology testing in early Lyme disease and after antibiotic treatment.”

While the study does not address why only one-third (35%) of these participants followed up with their healthcare providers about their ongoing symptoms, barriers to care have been well documented in other studies.

Specifically, data from MyLymeData, the largest Lyme disease patient registry, documented barriers specific to patients with persistent Lyme disease, including lack of insurance coverage, healthcare costs, travel time and distance to obtain care, and availability of care.

Participants in this study provided samples to the Lyme Disease Biobank, which collects early and persistent Lyme disease patient samples, postmortem and surgical tissue, as well as controls.

“The Lyme Disease Biobank was visionary in recognizing early on that progress in research was dependent upon having a large number of well-characterized samples from patients with diverse manifestations of Lyme disease available for study,” said Linden Hu, MD, professor of Immunology at Tufts Medical School, who collaborates with Lyme Disease Biobank.

“Many research groups, including my own, have greatly benefited from Lyme Disease Biobank samples, and studies of this size and magnitude would not have been possible without its existence.”

______________

**Comment**

The CDC test misses most cases of ALL Lyme and is worthless.

For More:

Category:

Activism, Lyme, research, Testing

Autism Reversal in Twin Girls & RFK Announces Thimerosal Ban

https://www.theepochtimes.com/health/autism-reversal-in-twin-girls-through-lifestyle-and-environmental-changes-new-study

Autism Reversal in Twin Girls Through Lifestyle and Environmental Changes: Case Study

Article Excerpts:
 
The twins received routine vaccinations at three and six months, but no further vaccination until 14 months. The girls were given acetaminophen before and after vaccination.

Initial Symptoms

The girls’ parents observed some initial symptoms. One twin had sensitivity to changes, eczema, and digestive issues, and the other had problems making eye contact, babbling communication, difficulty breastfeeding, and decreased muscle tone (hypotonia).

 
In March 2021, the girls received the series of vaccines that had been delayed due to the COVID-19 pandemic. After this round of vaccinations, their parents noticed a worsening of some symptoms, including “significant language loss” for one of the girls, who began communicating using only single words.

ASD Diagnosis

Due to the worsening symptoms, the twins were evaluated for ASD, and both subsequently met the criteria for DSM-5 (Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition) ASD diagnosis.

Lifestyle and Environmental Interventions

After their diagnosis, the twins’ parents began a comprehensive, personalized approach to address their daughters’ condition. Their approach was holistic and non-pharmacological and considered a variety of potential environmental and biological factors influencing ASD.

 
The interventions and support for both the twins and their parents began after the twins’ diagnosis at approximately 20 months of age and continued over the following two years. The following is a summary of their interventions and support:
 
Brief SUMMARY:
  • Dietary changes
  • Supplements
  • Speech and occupational therapy
  • Addressed environmental toxins

The twins achieved a reversal of their diagnoses of level 3 ASD. Significant improvements were seen in their social interactions, communication skills, and behavioral patterns.   Both twins “improved dramatically,” with one going from a score of 76 to 36 in seven months, and the other from 43 to 4 over the same period.

The study notes that the improvements were so profound the pediatrician exclaimed that one of the girls had undergone “a kind of miracle.”

(See link for article)

______________

HHS Secretary Robert Kennedy Jr. Announces Thimerosal ban.

After more than 20 years of delay, I’m proud to finally deliver on a long-overdue promise: protecting our most vulnerable from unnecessary mercury exposure. ~ Robert F. Kennedy, Secretary HHS 

More and more experts are calling for a retraction of the terribly flawed Danish study supposedly proving aluminum in vaccines isn’t harmful or in anyway cause autism.  RFK calls the study a ‘deceitful propaganda stunt,’ and Steve Kirsch states an AI analysis cites 5 reasons for retraction:

  1. the ‘evolving’ supplement and data manipulation which now reports 5,200 neurodevelopmental events (autism, ADHD, etc.), up from the 2,239 events in the original version  Oops
  2. the short follow-up period which gives a systematic underestimation of risk
  3. institutional conflicts of interest and data suppression
  4. statistical obfuscation and suppression of supplementary data
  5. the erosion of public trust if left as is due to conflicts of interest, data manipulation, selective reporting, and institutional whitewashing

For more:

Category:

Activism, Autism, diet and nutrition, Gut Health, Inflammation, research, Treatment, vaccines

How Much Undiagnosed Lyme is Driving the Chronic Disease Epidemic of Our Time?

https://www.change.org/p/the-us-senate-calling-for-a-congressional-investigation-of-the-cdc-idsa-and-aldf/u/33771723?

How much undiagnosed Lyme is driving the chronic disease epidemic of our time?

Carl Tuttle
Hudson, NH, United States
Aug 6, 2025

The attached photo complements this petition update and can be found here:

Children with Autism Spectrum Disorder
My son tested positive for Lyme Disease.
https://community.babycenter.com/post/a55368175/my_son_tested_positive_for_lyme_disease

Consider the following…..

“We will only treat those with a bullseye rash and/or a positive two-tier serological test. All else will filter into the healthcare system and if the spirochete is anything like syphilis left untreated it should turn into a moneymaker.”

I have heard through the Lyme community that only 15% of actual cases test positive; those with a robust immune response typically seen in the swollen knee presentation of the disease (Lyme arthritis). The 1994 Dearborn Conference established stringent testing setting the bar too high which was more likely to be positive with the swollen knee. They also removed the two most important markers (band 31 and 34. Outer surface proteins A and B)

Those markers needed to be removed for vaccine development of an OspA based vaccine because everyone who received those shots would test positive for Lyme disease.

The CDC estimates yearly cases of Lyme at 476,000

If 476,000 represents 15% of the actual cases, the other 3,173,333 filter down through the medical system to be treated for something else.

Interviewed Lyme patients in the documentary Under our Skin say the following:
 
-I was misdiagnosed with chronic fatigue syndrome
 
-I was misdiagnosed with MS
 
-I was misdiagnosed with Lupus
 
-I was misdiagnosed with Fibromyalgia
 
-I was misdiagnosed with ALS

Study detects tick-borne illness in teens hospitalized for depression
https://www.lymedisease.org/hospitalized-teens-lyme-depression/

June 10, 2021

-Ten patients were diagnosed with DSM-5 Major Depressive Disorder, seven were additionally diagnosed with Generalized Anxiety Disorder, and three had made serious suicide attempts.

-Ten adolescents picked at random with mental illness severe enough that they required institutionalization—nine of them had evidence of tick-borne infections and nine had evidence of autoimmune encephalitis

What was it that the CDC learned from the Tuskegee experiment when senator Ted Kennedy exposed the crime?

What happens when Lyme is left untreated as the Tuskegee Airman were?

There are dozens of studies from two continents identifying borrelia in the brains of Alzheimer’s patients and one NIH study claiming they could not find the Lyme disease spirochete. A coauthor of that single study is Adriana Marques, gatekeeper of who receives funding for Lyme disease research at the NIH. Marques used serology to claim there was no evidence of an association between Lyme disease and autism.

How many grants has Marques awarded to research chronic Lyme disease?

There are 700 peer reviewed studies identifying persistent infection and 2 NIH studies (by the same researcher!) that claim they could not find the Lyme disease spirochete in those treated following the IDSA’s treatment guideline.

Currently There is a Lyme disease vaccine in stage III clinical trials.

Does a chronic relapsing seronegative disease fit the vaccine model?

How do you prove vaccine efficacy in the general population if we do not know who has or does not have the infection? (immune suppressive infection)

Pfizer is using culture, PCR, DNA sequencing and serology testing in the trial participants to gauge efficacy because serology is so unreliable yet it has been the only lab test offered to the public for the past 30yrs. Let that sink in!

The current serological test for Lyme disease cannot be used to gauge treatment failure or success which makes it the ideal tool for concealing chronic infection.

Advanced Laboratory Services developed a culture test claiming 80% positive results. The CDC’s Barbera Johnson effectively put them out of business claiming contamination issues.

If that is the case why didn’t the CDC work directly with Advanced Laboratory Services to perfect their direct detection culture method?

Milford Molecular Diagnostics was working directly with the CDC on proficiency testing of their DNA sequencing test for Lyme disease. When Dr Sin Lee published a case of chronic Lyme proven through DNA sequencing all communication with the CDC ended abruptly with no explanation. As a result, Dr. Lee filed a $57.1 million lawsuit against the CDC.  Proving chronic Lyme disease threatened the existing false public health narrative.

George Mason University’s urine antigen test was eliminated from the LymeX prize competition and voted out by Adriana Marques but in the same month received a $1,176,645 grant in federal funding from the U.S. Department of the Army “to revolutionize Lyme disease detection and diagnosis with urine testing.” Many of us believed that the urine antigen test offered the best hope for the detection of Lyme in all stages of disease. Was this technology eliminated because the test threatened the existing IDSA/CDC dogma as it could detect chronic Lyme (which must never be identified) as this would expose the truth? By the way, Galaxy validation data (unpublished) shows that their Nanotrap® Urine Test will often confirm active infection in patients with negative TTT (Two-Tiered Testing) serology results.

SUMMARY

Is it possible that a large portion of the chronic diseases of our time (with no known etiology) are in fact a result of Lyme disease left untreated and there has been a concerted effort into hiding/avoiding the truth to preserve that profitable revenue stream in treating these chronic diseases? Finding the correct treatment for Lyme in all stages of disease is not in the best interest of a pharmaceutical industrial complex hell-bent on treating (not curing) with a lifetime of expensive drugs.

Carl Tuttle

Category:

Activism, Autism, Lyme